Iodine levels and papillary thyroid cancer characteristics
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at how iodine levels in your body relate to papillary thyroid cancer. It aims to understand the condition better, which may help with future treatment and prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have lived in the same area for at least 5 years
- You have been diagnosed with papillary thyroid cancer and are scheduled for surgery
- You do not have any other type of cancer
- You do not have serious heart, liver, or kidney conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how doctors and patients can decide together on the best way to treat low-risk thyroid cancer. It aims to help you choose a treatment that fits your values and needs, while keeping your cancer under control.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study looks at how iodine levels in your diet relate to thyroid cancer. If you have already had surgery for thyroid cancer, doctors will review your medical records and follow your health over time.
This study looks at how much iodine your body absorbs after you follow a low-iodine diet before radioactive iodine treatment (131I) for thyroid cancer. It may help improve how safely and effectively this treatment is planned.
This early-stage study tests how well a special iodine scan (using iodine-124) can help plan treatment with radioactive iodine (iodine-131) for thyroid cancer that has spread. It may help doctors decide the right way to measure and target radioiodine-avid (radioiodine-absorbing) metastases.
This Phase 1 study tests how doctors plan a combination of two radiation approaches—external beam radiation and radioactive iodine—for thyroid cancer that is not fully responding to standard treatment. It may help people who still have iodine-avid tumor spots, but whose iodine uptake looks too low to work well with radioactive iodine alone.
Hear when a new Papillary Thyroid Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.